Accessibility Menu
 
Surgical Innovations Group Plc logo

Surgical Innovations Group Plc

(LSE) SUN

Current Price$0.47
Market Cap$419.77M
Since IPO (1992)-99%
5 Year-85%
1 Year-10%
1 Month+0%

Surgical Innovations Group Plc Financials at a Glance

Market Cap

$419.77M

Revenue (TTM)

$24.45M

Net Income (TTM)

$2.06M

EPS (TTM)

$-0.15

P/E Ratio

-3.00

Dividend

$0.00

Beta (Volatility)

-0.20 (Low)

Price

$0.47

Volume

374,034

Open

$0.50

Previous Close

$0.47

Daily Range

$0.40 - $0.50

52-Week Range

$0.33 - $0.75

SUN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surgical Innovations Group Plc

Industry

Healthcare Equipment and Supplies

CEO

David John Marsh

Headquarters

Leeds, LS16 6QZ, GB

SUN Financials

Key Financial Metrics (TTM)

Gross Margin

28%

Operating Margin

-4%

Net Income Margin

-12%

Return on Equity

-15%

Return on Capital

-5%

Return on Assets

-12%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$419.77M

Shares Outstanding

932.82M

Volume

374.03K

Short Interest

0.00%

Avg. Volume

293.11K

Financials (TTM)

Gross Profit

$3.44M

Operating Income

$791.00K

EBITDA

$99.00K

Operating Cash Flow

$74.00K

Capital Expenditure

$335.00K

Free Cash Flow

$409.00K

Cash & ST Invst.

$195.00K

Total Debt

$1.24M

Surgical Innovations Group Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$6.14M

+8.8%

Gross Profit

$1.92M

+11.4%

Gross Margin

31.26%

N/A

Market Cap

$419.77M

N/A

Market Cap/Employee

$5.25M

N/A

Employees

80

N/A

Net Income

$21.00K

+105.6%

EBITDA

$373.00K

+473.8%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$1.40M

-157.6%

Accounts Receivable

$2.60M

+21.8%

Inventory

$2.60M

-27.1%

Long Term Debt

$465.00K

-65.5%

Short Term Debt

$473.00K

-21.9%

Return on Assets

-12.48%

N/A

Return on Invested Capital

-4.85%

N/A

Free Cash Flow

$264.00K

+36.7%

Operating Cash Flow

$239.00K

-113.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RUA.LRUA Life Sciences plc
$15.00+11.11%
GDR.LGenedrive Plc
$0.95+0.00%
TRX.LTissue Regenix Group plc
$7.25+0.00%
MHC.LMyHealthChecked PLC
$8.75-2.78%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$188.63+0.03%
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About SUN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.